A detailed history of Vident Advisory, LLC transactions in Haleon PLC stock. As of the latest transaction made, Vident Advisory, LLC holds 29,333 shares of HLN stock, worth $271,623. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,333
Previous 29,210 0.42%
Holding current value
$271,623
Previous $248 Million 2.3%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $985 - $1,062
123 Added 0.42%
29,333 $242 Million
Q1 2024

May 14, 2024

SELL
$8.02 - $8.67 $12,567 - $13,585
-1,567 Reduced 5.09%
29,210 $248 Million
Q4 2023

Feb 14, 2024

BUY
$7.78 - $8.62 $75,380 - $83,519
9,689 Added 45.95%
30,777 $253 Million
Q3 2023

Feb 21, 2024

SELL
$7.85 - $8.94 $76,058 - $86,619
-9,689 Reduced 31.48%
21,088 $176 Million
Q3 2023

Nov 14, 2023

BUY
$7.85 - $8.94 $165,540 - $188,526
21,088 New
21,088 $176 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.